|
ZNF384 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.58739999999558E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.373500E-04 |
| Normal-vs-Stage2 |
8.302600E-03 |
| Normal-vs-Stage3 |
2.04719999999936E-05 |
| Normal-vs-Stage4 |
8.606700E-04 |
| Stage1-vs-Stage2 |
9.556600E-01 |
| Stage1-vs-Stage3 |
1.263830E-01 |
| Stage1-vs-Stage4 |
5.040400E-01 |
| Stage2-vs-Stage3 |
3.495400E-01 |
| Stage2-vs-Stage4 |
6.575200E-01 |
| Stage3-vs-Stage4 |
6.556600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.52700000000717E-05 |
| Normal-vs-AfricanAmerican |
1.038810E-01 |
| Normal-vs-Asian |
5.402000E-02 |
| Caucasian-vs-AfricanAmerican |
3.703200E-01 |
| Caucasian-vs-Asian |
1.532640E-01 |
| AfricanAmerican-vs-Asian |
8.924200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.598800E-03 |
| Normal-vs-Female |
2.0390999999953E-05 |
| Male-vs-Female |
4.033200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.302790E-03 |
| Normal-vs-Age(41-60Yrs) |
4.035800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.58965000000011E-05 |
| Normal-vs-Age(81-100Yrs) |
3.380800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.177200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.089700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.579400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.239200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.602200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.562200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.959600E-03 |
| Classical-VS-Follicular |
3.604400E-02 |
| Classical-VS-Other |
6.049800E-01 |
| Classical-VS-Normal |
1.763240E-03 |
| Tall-VS-Follicular |
1.768440E-01 |
| Tall-VS-Other |
4.826800E-01 |
| Tall-VS-Normal |
3.07399999999181E-06 |
| Follicular-VS-Other |
8.147800E-01 |
| Follicular-VS-Normal |
1.638470E-04 |
| Other-VS-Normal |
1.108400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.200300E-04 |
| Normal-vs-N1 |
1.000450E-03 |
| N0-vs-N1 |
8.341600E-01 |
|
|
